AbbVie: raises dividend with quarterly results
(CercleFinance.com) - On its quarterly earnings call, AbbVie has announces that its Board of Directors has increased its dividend for 2024 by 4.
7% to $1.55 per share per quarter, starting in February 2024.
Q3 adjusted EPS fell 19.4% to $2.95 on revenues of over $13.9bn, down 5.8% in operating terms, due to declines in its immunology, oncology and aesthetics portfolios.
Nevertheless, the healthcare group has raised its adjusted EPS guidance range for FY 2023 from $10.86-11.06 to $11.19-11.23, as well as its adjusted EPS base guidance for FY 2024 from $10.70 to $11.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
7% to $1.55 per share per quarter, starting in February 2024.
Q3 adjusted EPS fell 19.4% to $2.95 on revenues of over $13.9bn, down 5.8% in operating terms, due to declines in its immunology, oncology and aesthetics portfolios.
Nevertheless, the healthcare group has raised its adjusted EPS guidance range for FY 2023 from $10.86-11.06 to $11.19-11.23, as well as its adjusted EPS base guidance for FY 2024 from $10.70 to $11.
Copyright (c) 2023 CercleFinance.com. All rights reserved.